Insider buying by corporate officers should be taken as optimistic visions of the future prospects of their companies and their stock prices.
These managed care stocks can withstand China, politics and a slowdown in the economy.
Cardinal Health's depressed stock price may be poised for a rebound.
Shares of the maker of Botox are struggling despite its latest results exceeding expectations.
And Cognizant Technology Solutions currently provides the former type of investor with a rare opportunity.
Shares of Dunkin's Brands and Planet Fitness appear to be expensive in light of the amount of debt the companies carry.
Revenue is stabilizing with new treatment lines, and this stock may be a soon be a buy.
But is a Teva turnaround still coming after the stock's 70% loss in the past five years?
Aetna's additive effects on CVS's earnings might be front and center, but it isn't fully actualized just yet.
As CVS Health's stock continues to run, management's careful approach should be encouraging for beleaguered investors.